Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Amgen Inc (AMGN)  
$286.30 4.53 (1.61%) as of 4:30 Wed 3/27


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 585,690,000
Market Cap: 167.68(B)
Last Volume: 2,256,036 Avg Vol: 2,733,398
52 Week Range: $214.27 - $324.56
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 100     S&P 500
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  499
Guru Rank Value     : 3
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 12,096 21,654 43,486
Total Sell Value $0 $3,300,412 $5,808,718 $11,189,871
Total People Sold 0 2 3 6
Total Sell Transactions 0 2 3 9
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 2150
  Page 1 of 86  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Khosla Rachna SVP, Business Development   •       •      –    2024-03-18 4 D $268.87 $117,765 D/D (438) 8,190     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2024-03-18 4 D $268.87 $5,527,967 D/D (20,560) 664,077     -
   Griffith Peter H. EVP & CFO   •       •      –    2024-03-18 4 D $268.87 $1,389,520 D/D (5,168) 34,710     -
   Gordon Murdo EVP, Global Commercial Ops   •       •      –    2024-03-18 4 D $268.87 $1,737,169 D/D (6,461) 51,321     -
   Reese David M EVP & Chief Technology Officer   •       •      –    2024-03-18 4 D $268.87 $1,667,532 D/D (6,202) 60,666     -
   Busch Matthew C. VP, Finance & CAO   •       •      –    2024-03-18 4 D $268.87 $39,255 D/D (146) 4,670     -
   Miller Derek SVP, Human Resources   •       •      –    2024-03-18 4 D $268.87 $127,713 D/D (475) 8,419     -
   Graham Jonathan P EVP & Gen. Counsel & Secy.   •       •      –    2024-03-18 4 D $268.87 $1,580,687 D/D (5,879) 34,232     -
   Santos Esteban EVP, Operations   •       •      –    2024-03-18 4 D $268.87 $1,650,055 D/D (6,137) 70,213     -
   Grygiel Nancy A. SVP & CCO   •       •      –    2024-03-18 4 D $268.87 $189,016 D/D (703) 12,220     -
   Khosla Rachna SVP, Business Development   •       •      –    2024-03-06 4 A $0.00 $0 D/D 1,256 8,597     -
   Graham Jonathan P EVP & Gen. Counsel & Secy.   •       •      –    2024-03-06 4 A $0.00 $0 D/D 11,760 39,925     -
   Miller Derek SVP, Human Resources   •       •      –    2024-03-06 4 A $0.00 $0 D/D 1,311 8,863     -
   Busch Matthew C. VP, Finance & CAO   •       •      –    2024-03-06 4 A $0.00 $0 D/D 418 4,799     -
   Grygiel Nancy A. SVP & CCO   •       •      –    2024-03-06 4 A $0.00 $0 D/D 1,954 12,866     -
   Gordon Murdo EVP, Global Commercial Ops   •       •      –    2024-03-06 4 A $0.00 $0 D/D 12,924 57,569     -
   Santos Esteban EVP, Operations   •       •      –    2024-03-06 4 A $0.00 $0 D/D 12,278 76,125     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2024-03-06 4 A $0.00 $0 D/D 41,133 683,910     -
   Reese David M EVP & Chief Technology Officer   •       •      –    2024-03-06 4 A $0.00 $0 D/D 12,407 66,653     -
   Griffith Peter H. EVP & CFO   •       •      –    2024-03-06 4 A $0.00 $0 D/D 10,338 39,250     -
   Bradner James E. EVP, R&D, & Chief Sci. Officer   •       •      –    2024-02-09 4 A $0.00 $0 D/D 22,393 22,393     -
   Grygiel Nancy A. SVP & CCO   •       •      –    2023-12-04 4 S $273.03 $572,276 D/D (2,096) 10,874 -3%     
   Reese David M EVP, Research and Development   •       •      –    2023-11-28 4 GD $0.00 $0 D/D 165 54,164     -
   Graham Jonathan P EVP, Gen. Counsel & Secy.   •       •      –    2023-11-08 4 S $272.81 $2,728,136 D/D (10,000) 28,078 0%     
   Busch Matthew C. VP, Finance & CAO   •       •      –    2023-11-05 4 D $269.86 $67,195 D/D (249) 4,367     -

  2150 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 86
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed